Everand Logo

Welcome to Everand!

  • STAT

    Before a biotech stock debacle, one Republican congressman made a prescient trade

    Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech's stock tanked. The stock was a favorite of several GOP representatives.
    by Damian Garde Jul 03, 2017 2 minutes
    Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech company's stock tanked.

    A biotech stock meltdown last week led to huge paper losses for several congressional Republicans who had bought into the tiny company. But one politician-turned-investor was spared. Turns out, he had sold his shares just two weeks before news of a negative clinical trial decimated the company’s value.

    Rep. John Culberson of Houston was among a half dozen House Republicans to invest in Innate Immunotherapeutics,

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
    Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

    Related Books & Audiobooks